Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 11/20 | 0.50 |
| ▸ | CA2 | P00918 | 11/20 | 0.50 |
| ▸ | CA9 | Q16790 | 7/20 | 0.50 |
| ▸ | CA12 | O43570 | 6/20 | 0.50 |
| ▸ | CA4 | P22748 | 6/20 | 0.50 |
| ▸ | CA6 | P23280 | 6/20 | 0.50 |
| ▸ | CA5A | P35218 | 6/20 | 0.50 |
| ▸ | CA7 | P43166 | 6/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 6/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 6/20 | 0.50 |
| ▸ | CA13 | Q8N1Q1 | 4/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | APEX1 | P27695 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 4/20 | 0.47 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.44 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Clofenamide SCHEMBL310408 | 0.88 | CA1 (0.59) | CA1CA2CA9CA12CA4 | |
| Clofenamide SCHEMBL30748198 | 0.88 | CA1 (0.59) | CA1CA2CA9CA12CA4 | |
| Clofenamide SCHEMBL28383730 | 0.86 | CA1 (0.57) | CA1CA2CA9CA12CA4 | |
| Clofenamide SCHEMBL27524784 | 0.86 | CA1 (0.57) | CA1CA2CA9CA12CA4 | |
| SCHEMBL7124035 | 0.85 | POLB (0.47) | CA1CA2CA9CA12CA4 | |
| SCHEMBL17478768 | 0.84 | CA2 (0.55) | CA1CA2CA9CA12CA4 | |
| SCHEMBL11009995 | 0.82 | LMNA (0.51) | CA1CA2CA9CA12CA4 | |
| Clofenamide SCHEMBL28282642 | 0.79 | CA1 (0.50) | CA1CA2CA9CA12CA4 | |
| SCHEMBL11010701 | 0.79 | CA1 (0.46) | CA1CA2CA9CA12CA4 | |
| SCHEMBL29469880 | 0.78 | VCAM1 (0.55) | CA1CA2CA9CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12398341-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-08-26 | — | — | US | claimed |
| US-12247180-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-03-11 | — | — | US | claimed |
| EP-4686751-A1 | PROCESS FOR THE PREPARATION OF A DETERGENT CONCENTRATE | Henkel AG & Co. KGaA (DE) | 2026-02-04 | — | — | EP | disclosed |
| US-12398341-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-08-26 | — | — | US | disclosed |
| WO-2025131407-A1 | HAND DISHWASHING DETERGENT CONCENTRATE | HENKEL AG & CO. KGAA (DE) | 2025-06-26 | — | — | WO | disclosed |
| US-20250177596-A1 | POLYESTER SOLID ARTICLE COMPRISING HYDROPHOBIC MATERIAL | THE PROCTER & GAMBLE COMPANY | 2025-06-05 | — | — | US | disclosed |
| US-20250177597-A1 | POLYESTER-POLYETHER SOLID ARTICLE COMPRISING HYDROPHOBIC MATERIAL | THE PROCTER & GAMBLE COMPANY | 2025-06-05 | — | — | US | disclosed |
| EP-4006130-B1 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | SYMRISE AG (DE) | 2025-04-09 | — | — | EP | disclosed |
| EP-4531800-A1 | TWO-STAGE DYEING METHOD FOR INCREASING THE INTENSITY OF COLORATIONS WITH NATURAL DYES | Henkel AG & Co. KGaA (DE) | 2025-04-09 | — | — | EP | disclosed |
| US-12247180-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-03-11 | — | — | US | disclosed |
| CN-119584860-A | Comprising biodegradable microcapsule composition | 奇华顿股份有限公司 | 2025-03-07 | — | — | CN | disclosed |
| US-7781613-B2 | Substituted N-aminomethylene sulfonamides, production and use thereof as medicaments | SANOFI-AVENTIS (FR) | 2010-08-24 | — | — | US | disclosed |
| US-20080069851-A1 | SUBSTITUTED N-AMINOMETHYLENE SULFONAMIDES, PRODUCTION AND USE THEREOF AS MEDICAMENTS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-03-20 | — | — | US | disclosed |
| EP-1841731-A1 | SUBSTITUTED AMINOMETHYLENE SULPHONAMIDES, PRODUCTION AND USE THEREOF AS MEDICAMENTS | Sanofi-Aventis (FR) | 2007-10-10 | — | — | EP | disclosed |
| WO-2006074957-A9 | SUBSTITUTED AMINOMETHYLENE SULPHONAMIDES, PRODUCTION AND USE THEREOF AS MEDICAMENTS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2007-07-12 | — | — | WO | disclosed |
| WO-2006074957-A1 | SUBSTITUTED AMINOMETHYLENE SULPHONAMIDES, PRODUCTION AND USE THEREOF AS MEDICAMENTS | SANOFI-AVENTIS (DE) | 2006-07-20 | — | — | WO | disclosed |
| EP-0088350-B1 | CARBOXYALKYL DIPEPTIDES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING CORPORATION (US) | 1985-02-20 | — | — | EP | disclosed |
| US-4431645-A | CARDIOVASCULAR DISORDERS; DIURETICS | SCHERING CORPORATION (US) | 1984-02-14 | — | — | US | disclosed |
| US-4431644-A | CARDIOVASCULAR DISORDERS; DIURETICS | SCHERING CORPORATION (US) | 1984-02-14 | — | — | US | disclosed |
| EP-0088350-A1 | Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them | SCHERING CORPORATION (US) | 1983-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080069851-A1 | SUBSTITUTED N-AMINOMETHYLENE SULFONAMIDES, PRODUCTION AND USE THEREOF AS MEDICAMENTS | LIPE, STS, ARSA | CA1 3065/4885CA2 2004/4885CA9 2620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.